Why, in the 40 years since the onset of the HIV pandemic, do we still not have a cure for the nearly 40 million people globally living with HIV?

Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

Alla Pinzour has lived with melanoma for 15 years. A new therapy offered at University of Chicago Medical Center used her own ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September ...

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Keywords: Vitiligo, Artificial Intelligence, Novel Therapies Dermatology, Patient Care, Clinical Research, Diagnostic Tools, Treatment Outcomes, AI in Medicine, Skin Disorders Important Note: All ...